MedPath

Floxuridine

Generic Name
Floxuridine
Drug Type
Small Molecule
Chemical Formula
C9H11FN2O5
CAS Number
50-91-9
Unique Ingredient Identifier
039LU44I5M
Background

An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection. Floxuridine is available as a sterile, nonpyrogenic, lyophilized powder for reconstitution. When administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Indication

For palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means. Also for the palliative management of liver cancer (usually administered by hepatic intra-arterial infusion).

Associated Conditions
Stage 4 gastrointestinal adenocarcinoma
Associated Therapies
Palliative Treatment

Regional Chemotherapy Shows Promise in Treating Colorectal Cancer Metastatic to the Liver

A study involving 93 patients with colorectal cancer metastatic to the liver treated with hepatic arterial infusion of 5-fluorodeoxyuridine (FUDR) showed significant tumor size reduction and prolonged survival, especially in patients without extrahepatic metastases.
© Copyright 2025. All Rights Reserved by MedPath